Ailux Biologics, a division of XtalPi, is an end-to-end AI-powered biologics discovery and engineering platform. Created at the intersection of artificial intelligence and wet-lab excellence, Ailux is at the forefront of revolutionizing the way biologics are developed, leveraging the power of artificial intelligence to address the most complex challenges facing the industry.

Ailux’s technology stack includes:
- XtalFold, a state-of-the-art Ab-Ag complex structure prediction algorithm demonstrated superior to Alphafold-Multimer, as evidenced by industry-standard scoring metrics such as DOCKQ and iRMSD.
- XenProt, comprehensive suite of AI models that includes generative large language models capable of predicting binding affinity, developability and immunogenicity of biologics.
- End-to-end wetlab discovery and characterization services, including single B cell microfluidics, synthetic smart display libraries and hybridoma.

Ailux technology has proven effective targeting GPCR’s and ion channels, as well as addressing engineering challenges like pH-selectivity, super humanization, and multiparametric developability. Collaborate with Ailux to enable our innovative technologies for your most challenging projects or to elevate the results of more conventional programs.